Validation of THCC-RI in the Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study

Hepatology

Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world study

Hepatology

Tovoli F, Iavarone M, Cabibbo G, Marra F, Vivaldi C, Dalbeni A, Ponziani FR, Palloni A, Bergamo F, Rimassa L, Lani L, Federico P, Svegliati-Baroni G, Ielasi L, Mazzarelli C, De Lorenzo S, Sacco R, Bruccoleri M, Celsa C, Mastro A, Masi G, Auriemma A, Stella L, Toniutto P, Villani R, Lonardi S, Pressiani T, Piscaglia F, ARTE study group

doi: 10.1097/HEP.0000000000001725

Hepatology

Liver decompensation in patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab: a real-life study

Clin Gastroenterol Hepatol

Stella L, Pallozzi M, Cerrito L, Santopaolo F, Tovoli F, Hollande C, Sidali S, Stefanini B, Campani C, Pellegrini E, Cabibbo G, Marra F, Piscaglia F, Gasbarrini A, Pompili M, Bouattour M, Ponziani FR

doi: 10.1016/j.cgh.2024.12.028

Gastrointestinal Cancer

Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review

Cancer Treat Rev

Galli E, Patelli G, Villa F, Gri N, Mazzarelli C, Mangoni I, Sgrazzutti C, Ghezzi S, Sartore-Bianchi A, Belli LS, De Carlis L, Vanzulli A, Siena S, Bencardino K

doi: 10.1016/j.ctrv.2025.102908

Hepatology

Early occurrence of hepatic encephalopathy following TIPS-insertion is linked to impaired survival: a multicenter cohort study

Clin Gastroenterol Hepatol

Kabelitz MA, Sandmann L, Praktiknjo M, Mauz JB, Auer TA, Bruns T, Chang J, Fehrenbach U, Hinrichs J, Jansen C, Klöckner R, Kluwe J, Köhler M, Meyer C, Piecha F, Pollmanns MR, Ripoll C, Schultheiss M, Seifert LL, Stöhr F, Sturm L, Trebicka J, Zipprich A, Labenz C, Bettinger D, Maasoumy B, German Cirrhosis Study Group

doi: 10.1016/j.cgh.2025.01.024

Gastrointestinal CancerHepatology

Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma

J Hepatol

Yopp A, Chen M, Cheng AL, Kaseb A, Kudo M, Lee HC, Cha E, Hack SP, Lian Q, Spahn J, Wu C, Qin S, Chow PK

doi: 10.1016/j.jhep.2026.01.006

Gastrointestinal Cancer

Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study

Lancet Oncol

Alves N, Schuurmans M, Rutkowski D, Saha A, Vendittelli P, Obuchowski N, Liedenbaum MH, Haldorsen IS, Molven A, Yakar D, Geerdink J, van Koeverden S, Riviere DM, Venderink W, de Haas R, Kim N, Löhr JM, Suman G, Maier-Hein KH, Hahn HK, Wang W, Yuille AL, Kambadakone A, Fishman EK, Verbeke C, Litjens G, Hermans JJ, Huisman H, PANORAMA consortium

doi: 10.1016/S1470-2045(25)00567-4

Hepatology

Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications

Gut

Bueloni B, G Fernandez-Barrena M, Fiore E, Avila MA, Bayo J, Mazzolini GD

doi: 10.1136/gutjnl-2025-336317

Hepatology

Elevated CircYthdc2 expression is correlated with aggressive features and poor progression-free survival in hepatocellular carcinoma

BMC Gastroenterol

Gong Y, Li X, Wang M

doi: 10.1186/s12876-025-04231-0

Gastrointestinal Cancer

Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study

Lancet Gastroenterol Hepatol

Mahajan UM, Oehrle B, Goni E, Strobel O, Kaiser J, Grützmann R, Werner J, Friess H, Gress TM, Seufferlein TW, Uhl W, Will U, Neoptolemos JP, Wittel UA, Vornhülz M, Sirtl S, Beyer G, Regel I, Boeck S, Heinemann V, Frost F, Steveling A, Völzke H, Petersmann A, Nauck M, Weber E, Kamlage B, Lerch MM, Mayerle J, METAPAC trial investigators

doi: 10.1016/S2468-1253(25)00056-1

Related content

Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world study

Liver decompensation in patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab: a real-life study

Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review

Early occurrence of hepatic encephalopathy following TIPS-insertion is linked to impaired survival: a multicenter cohort study

Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma

Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study

Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications

Elevated CircYthdc2 expression is correlated with aggressive features and poor progression-free survival in hepatocellular carcinoma

Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study